The real benefit was breaking the lease. It was a cash drain on the business frm when PXS thought they could both develop and manufacture the drugs, but was way to big for the order book they had.
Exiting manufacture was a great idea !
Ann: Investor presentation - equity raising, page-11
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
-0.001(2.94%) |
Mkt cap ! $39.40M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.2¢ | $46.51K | 1.381M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 186766 | 3.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 196199 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |